Archive for category HE-Xpo

Integrating Big Data: How HealthCore is using Research to Improve Care, Safety, and Outcomes.

BIGDATA-USCompanies are striving to advance beyond the buzzword of Big Data to delivering real, actionable results that change the way our healthcare system works.  The power to access and analyze these enormous data sets, and then develop insights that can be acted upon at the patient, provider and policy level, can greatly improve our ability to both anticipate and treat illness.  Consistent with a global effort to improve healthcare value, Big Data can also help key stakeholders better understand the effectiveness and safety of interventions.  Treatment decisions, including the inputs into those decisions as well as the outputs (or the outcomes) can be more quickly and accurately assessed – in nearly real-time.  Who, in the healthcare industry, is poised to do this?  And what have we learned so far, using and interpreting healthcare big data, that can help us in the future?

HealthCore, a health services research organization, has been a leader in translating large data sets into real-world insight for two decades.  As a wholly-owned outcomes research subsidiary of Anthem, Inc., one of the nation’s leading health benefits companies, HealthCore will showcase their Big Data innovations with case studies and actual research examples, in an upcoming Virtual Conference on Wednesday, February 18, 2015, Actionable Insights into Health Policy, Practice and Outcomes Through Research and Big Data – with a Spotlight on Oncology, from 9:30am-11:30am ET with an encore presentation from 11:30am-1:30pm ET.

How are large integrated healthcare datasets being used to make a difference in patient outcomes, medical practice, and health policy?  Attend this two-hour event to find out.  Just click on the Register link below.

HealthCore.
presentation title

register button-shape 1 copy 3Download the Agenda.

healthcore-page-image

This event will take place in the interactive virtual environment of HE-Xpo®, and attendees will be able to view real-time presentations by seven senior executives of HealthCore, ask questions, visit a virtual Exhibit Booth, download educational materials from the Learning Center, and interact with presenters and other attendees in the virtual Lounge.  The meeting is free to attend; you may view the Agenda here and register here.  You will need a working internet connection to take part in this virtual conference.  Below is a preview of what will be presented.
MAGAZINE COVER
“There’s lots of Big Data out there with not a lot of robust insight,” says Marcus Wilson, PharmD, President, HealthCore. “There is a limit to what you can get from it without it being effectively integrated.”

Dr. Wilson will share his views on the industry’s future in terms of research collaborations and the promise of a unique integrated research environment and health care data analytics.

“We’re looking at practical approaches to accelerate the speed at which we can develop evidence in the general population, as well as specific populations, so that we can get this information in the hands of clinicians and benefit patients earlier,” said Mark Cziraky, PharmD, Vice President of Research at HealthCore.

There is increasing interest among the pharmaceutical industry and the payer community in developing unique partnerships that reflect collaboration, connectivity, and shared decision-making among major stakeholders. HealthCore has been an active participant in multiple collaborations with various pharmaceutical companies and payers focusing on the use of real-world evidence, with an aim to cut down on the typical 17-year time frame for research evidence to reach clinical practice. Mark Cziraky will speak at this virtual event on “Evolving Research Connectivity, Better Decisions for the Health Care Industry.” Dr. Cziraky will provide examples of the processes and desired goals of various real-world evidence research collaborations, and dive into some of the implications of the research that can be conducted when stakeholders connect towards the goal of improving health outcomes for patients. If you are part of an organization interested in forming alliances with stakeholders on real-world evidence collaboratives, you will not want to miss this presentation.

Vince Willey, PharmD. Staff VP, Industry Sponsored Research.

“HealthCore’s environment, with its data environment and experienced researchers, provides a unique opportunity for conducting research” said Vince Willey, PharmD, Staff Vice President of HealthCore’s Industry Sponsored Research Unit.  “It has the ability to pull in data from medical and pharmacy claims, clinical information from the physician, medical charts, and other information from patients that allow us to answer complex clinical, economic and health policy questions.”

Oncology therapeutics is one of the fastest growing arenas in healthcare, with cancer treatments estimated to exceed the $100 billion mark worldwide within the next few years. The promise of targeted cancer treatments, as well as the recent US and European focus on the cost-effectiveness of cancer treatments, have piqued interest in how data analytics can be used to maximize outcomes. Dr. Willey will present “A Focus on Oncology within HealthCore’s Research Environment.” He will describe the types of oncology data that are available, showcase insights derived from oncology data, and address the realized value to the healthcare industry. If you would like to better understand how data assets can be used to answer complex clinical and economic health outcomes questions in oncology, this session will be of utmost interest.

Crystal Holick, ScD. Sr. Dirctor, Safety and Epidemiology Research.

The promise of using healthcare big data to monitor safety is never far from the thoughts of many who believe that fundamental improvements in our healthcare system are on the next horizon. Crystal Holick, ScD is well-suited to delve into this topic, bringing experienced perspectives from her role as Senior Director, Safety and Epidemiology Research at HealthCore. Dr. Holick will provide an overview of how HealthCore’s research environment is used for greater insights into safety, and explore how these results were used by the pharmaceutical industry, payer audiences, and other stakeholders to improve care delivery, identify research opportunities, and advance patient outcomes. This presentation is also an important opportunity to learn more about how using databases for medical product safety assessment requires careful research consideration to ensure that the interpretation is both valid and based on rigorous analytic methods.

Nandini Selvam, PhD. Sr. Director, Government and Academic Research.In the past several years, HealthCore’s collaborative approaches have extended into new health care industry arenas, including government and academic groups, thereby marshaling expertise and sharing insights to improve health policy and practice.  If you work closely with academic institutions or government agencies, be sure to listen to this enlightening presentation by Nandini Selvam, PhD, Senior Director of HealthCore’s Government and Academic Research.

John Barron, PharmD. Staff VP, Payer and Provider Research.

Andrea DeVries, PhD. Sr. Director, Payer and Provider Research.

Rounding out this information-packed two-hour virtual event is a joint presentation by John Barron, PharmD and Andrea DeVries, PhD of HealthCore’s Payer and Provider Research division. Drs. Barron and DeVries have extensive experience managing hundreds of projects.  They will provide a practical and instructive presentation on “How Research Can Provide Actionable Information to Health Plans”.  Expect to hear case studies on how health plans can directly benefit from health services research to inform strategies, identify new opportunities, and gain insights into changing consumer and provider behavior.

Do you have some areas that you would like to see addressed? Some questions you would like to raise? Click on the Comment link below and share your views with HealthCore in advance.

Please do not miss this opportunity to attend the event on Wednesday, February 18, 2015, Actionable Insights into Health Policy, Practice and Outcomes Through Research and Big Data – with a Spotlight on Oncology, from 9:30am-11:30am ET with an encore presentation from 11:30am-1:30pm ET. Speakers will be available to answer your questions in real-time at the end of the 2-hour session.

If you have a conflict with this event on February 18th, you have the option to view the full presentation “on-demand” at any time. Register on the link below to receive instructions for “on-demand” access.

, , , , ,

No Comments

Real-World Evidence: Why Patients Matter.

Take 2 tablets and call me in the morning

We’ve moved, finally, beyond assuming that an off-the-cuff statement like “take 2 and call me in the morning” is first-quotesufficient.  But maybe we haven’t moved far enough to ask the important questions of “why isn’t it sufficient?”. Health Literacy and Cultural Competency are two buzzwords that health professionals are likely to encounter these days, and their importance in achieving a desired endpoint in patient care cannot be understated.

second-quoteSo what exactly does Health Literacy mean?  How do we implement a Cultural Competency in our healthcare system?  And most importantly, what do we need to know to understand how literacy and culture affect health outcomes and research conducted among a wide and diverse patient population?

Healthcare Providers, Researchers, Policy-Makers, and Patient Advocacy groups must consider what happens – or doesn’t happen – when we provide information or health directives to patients who can’t read – or, who may not be able to read on the level on which the information was written.  Sure, the “box may be checked” that the patient received healthcare information, but was it readable, understood, and acted upon?  Why or why not?

venn diagramBeyond literacy, we must also ask about (and understand) the patients’ culture.  To what extent does a patient’s personal identification, language, thoughts, communications, actions, customs, beliefs, values, and institutions influence beliefs and belief systems surrounding health, healing, wellness, illness, disease, and delivery of health services?

As health outcomes researchers and healthcare providers, we must consider both Health Literacy and Cultural Competency in the deployment of healthcare and the conduct of research, particularly real-world evidence (RWE) trials that are often conducted with diverse patient populations.

If you don’t feel you are doing this to the extent that is needed, then you need to hear Dr. Donney John, Founder & CEO of Urban Medical Solutions and Interim Executive Director of NOVAScripts Central, discuss some of these issues and more at the first ever Real-World Evidence virtual Summit hosted by HealthEconomics.Com (for more information or to register please go to: http://www.healtheconomics.com/home/1st-ever-virtual-summit-real-world-evidence/).  During his portion of the programming, Don will discuss why RWE should be a focal point for patient care. He’ll also discuss cultural competency and health literacy and what factors to consider in the design, implementation, and communication of results from RWE studies. RWE is important for helping patients feel they are understood and connected with their health. What role do patients play in the development of RWE? What role does RWE play in improving a patient’s management of their care?

So, don’t miss out on the chance to make sure you know what you need to know about Health Literacy and Cultural Competency for Real-World Evidence research.  Oh, and it’s free to attend.  And it’s virtual…meaning you can attend from anywhere on the globe, as long as you have an internet connection.

Thanks for downloading your copy of the Final Findings from the Survey 2014 on Real World Evidence_image001

register-buttondownload-button

Putting it all into PROspective

Any Pain

Patients Reported Outcomes (PROs) are acknowledged as a vital component to the complete healthcare picture, but they haven’t gained the traction they deserve. Join us at the RWE Virtual Summit where Linda Abetz-Webb, CEO of Patient-Centred Outcomes Assessment (P-COA), will discuss the compelling reasons why we should be measuring Patient Reported Outcomes. She’ll take a look at where things are now in the PRO world, and where they should be going. Linda will also delve into the ‘patient-centered outcomes’ terminology  (click here to see PCORI’s approach to a definition) that is flooding the healthcare headlines.  Linda will examine RWE from a patient perspective. Linda’s vast experience in this arena will provide for a lively presentation and help the audience gain some PROspective. To register for the Virtual Summit, please go to: http://www.healtheconomics.com/home/1st-ever-virtual-summit-real-world-evidence

“See” you on the 11th!

More about the Speakers

Donney John is a practicing pharmacist, healthcare consultant and entrepreneur, with considerable expertise in the areas of patient engagement, population health management, transition in care and mobile health technology solutions.  Don is the founder & CEO of Urban Medical Solutions and Interim Executive Director of NovaScripts Central, a non-profit pharmacy that provides free medications to uninsured patients in the northern Virginia area.  He is also the founder and CEO of Urban Medical Solutions, a health consulting company which provides consultative services focusing on clinical workflow and technology integration.  Don holds a Doctor of Pharmacy degree from St. John’s University in Queens, New York, and has completed a pharmacy residency with Massachusetts College of Pharmacy & Health Sciences.

 

Linda Abetz-Webb is the CEO of Patient-Centred Outcomes Assessment (P-COA). She has over 20 years of experience in developing, validating, and implementing clinical outcomes assessments (COA- patient, observer, and clinician reported). Linda has successfully utilized COAs to maximize market access and patient adherence. Her specific expertise is in pediatrics and/or rare diseases.

This blog posting was written by Meg Franklin, PharmD, PhD, Owner and President Franklin Pharmaceutical Consulting, LLC, on behalf of HealthEconomics.Com. Dr. Franklin may be reached at mfranklin.fpc@gmail.com or www.franklinpharmaceutical.com.

, , , , , , , , , , , , ,

No Comments